Eli Lilly and Companyand Livongo Health, a consumer digital health company focused on empowering all people with chronic conditions to live better and healthier lives has teamed up on a new strategic collaboration to study real-world evidence and develop new insights to reduce the burden on people living with diabetes.
The research collaboration will combine real-world behavioral studies and claims data to advance knowledge about effective interventions in diabetes care. The companies aim to contribute to medical literature in three areas:
1. Measure the impact of remote diabetes self-management education and support on clinical and healthcare cost outcomes
2. Understand drivers of healthy behaviors
3. Understand how people living with diabetes can stay more actively involved in their health
Livongo and Lilly aim to publish the results of their collaborative research studies to further advance diabetes care for people worldwide.
Livongo’s first diabetes management program targeted to people with either Type 1 or Type 2 diabetes is completely mobile, digital and personalized to the user. It allows people with diabetes to effectively manage important aspects of their illness on their own. It also allows them to easily keep their family members and care team informed in real-time.
Each Livongo for Diabetes user receives the company’s In Touch® blood glucose smartmeter, a proprietary mobile device that is the first cellular-enabled, two-way interactive blood glucose meter. The device captures a user’s biometric data and uploads it to a cloud-based inference engine where historical data, clinical rules and predictive modeling are used to convert it into useable information and support that is instantly returned back to the person with diabetes.
“These studies will have a direct impact on the lives of Livongo members,” said Jennifer Schneider, MD, chief medical officer, Livongo in a statement. “Livongo uses reinforcement learning to create customized and actionable insights that guide people to better manage their diabetes. The knowledge we gain from these studies will be incorporated into our diabetes management platform to help drive better health outcomes for our members.”
